Literature DB >> 1661757

Glucocorticoid- and estrogen-responsive elements in the 5'-flanking region of the rat angiotensinogen gene.

M Feldmer1, M Kaling, S Takahashi, J J Mullins, D Ganten.   

Abstract

We investigated the 5'-flanking region of the rat angiotensinogen gene to define the DNA elements conferring inducibility by glucocorticoids and estrogens. Two putative glucocorticoid-responsive elements (GREs) based on sequence comparison were identified. Here we report the functional importance of these sequences. We constructed several deletion mutants of the 5'-region in front of the bacterial reporter gene for chloramphenicol acetyltransferase (CAT). The angiotensinogen-CAT-reporter plasmids (pRagCAT) were transiently transfected into the rat hepatoma cells FTO 2B and Fe 33. All pRagCAT constructs in which the 5'-region contained at least one of the two GRE consensus sequences were stimulated by dexamethasone. On the other hand, deletion mutants containing no GRE sequences were not inducible with dexamethasone. In additional experiments, the transcriptional functions of the two putative GREs were assessed by cloning synthetic oligonucleotides encompassing the GRE sequences directly in front of the heterologous herpes simplex virus thymidine-kinase promoter. Our results showed that each synthetic GRE was capable of stimulating the heterologous TK promoter after administration of dexamethasone and that both GREs together act synergistically. We also investigated the transcriptional control of angiotensinogen by estrogen. Although no estrogen-responsive element consensus sequences were detectable by sequence comparison, we did identify sequences between -60 to -92 which conferred estrogen inducibility to the rat angiotensinogen gene. In this region, a so-called half-palindromic estrogen-responsive element is localized at nucleotides -87 to -91.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1661757     DOI: 10.1097/00004872-199111000-00005

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  8 in total

1.  Ageing-related cardiomyocyte functional decline is sex and angiotensin II dependent.

Authors:  Kimberley M Mellor; Claire L Curl; Chanchal Chandramouli; Thierry Pedrazzini; Igor R Wendt; Lea M D Delbridge
Journal:  Age (Dordr)       Date:  2014-02-25

2.  Identification of cis-regulatory sequences in the human angiotensinogen gene by transgene coplacement and site-specific recombination.

Authors:  Taku Shimizu; Takayuki Oishi; Akane Omori; Akiko Sugiura; Keiko Hirota; Hisanori Aoyama; Tomoko Saito; Takeshi Sugaya; Yasuhiro Kon; James Douglas Engel; Akiyoshi Fukamizu; Keiji Tanimoto
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

Review 3.  Heart failure in women.

Authors:  Denise D Barnard
Journal:  Curr Cardiol Rep       Date:  2005-05       Impact factor: 2.931

4.  Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease.

Authors:  Thomas Simon O'Hagan; Whitney Wharton; Patrick Gavin Kehoe
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 5.  Sex differences in the causes and natural history of heart failure.

Authors:  Bobbi L Hoppe; Denise D Hermann
Journal:  Curr Cardiol Rep       Date:  2003-05       Impact factor: 2.931

6.  Gender specific association of RAS gene polymorphism with essential hypertension: a case-control study.

Authors:  Kh Dhanachandra Singh; Ajay Jajodia; Harpreet Kaur; Ritushree Kukreti; Muthusamy Karthikeyan
Journal:  Biomed Res Int       Date:  2014-04-17       Impact factor: 3.411

7.  HDAC9 is an epigenetic repressor of kidney angiotensinogen establishing a sex difference.

Authors:  Camille T Bourgeois; Ryousuke Satou; Minolfa C Prieto
Journal:  Biol Sex Differ       Date:  2017-05-30       Impact factor: 5.027

8.  High blood pressure in transgenic mice carrying the rat angiotensinogen gene.

Authors:  S Kimura; J J Mullins; B Bunnemann; R Metzger; U Hilgenfeldt; F Zimmermann; H Jacob; K Fuxe; D Ganten; M Kaling
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.